Tate & Lyle PLC

Public consensus   -   Last updated 04/04/25

Contributors

  • 7 FY25 - Continuing based on
  • 7 FY26 based on
Reporting currency: GBP
Reporting unit: Millions
FY25 - Continuing
CONSENSUS
04/04/25
FY26
CONSENSUS
04/04/25
Volume change (%)
Volume change - Food & Beverage Solutions
Total Food & Beverage Solutions
3
5
Volume change - SPLENDA® Sucralose
SPLENDA® Sucralose
7
1
Volume change - Primary Products Europe
Primary Products Europe
(6)
(19)
Group Income Statement (£m)
Revenue - Food & Beverage Solutions
Food & Beverage Solutions
1,263
1,288
Revenue - Sucralose
Sucralose
179
181
Revenue - Primary Products Europe
Primary Products Europe
89
73
Revenue - Continuing Operations
1,766
2,194
Adjusted EBITDA
Food & Beverage Solutions
286
297
Sucralose
56
57
Primary Products Europe
(4)
(4)
Adjusted EBITDA - Continuing Operations
377
479
Less: Depreciation and adjusted amortisation
(93)
(137)
Adjusted operating profit - Continuing Operations
284
342
Net finance expense
(19)
(46)
Adjusted profit before tax - Continuing Operations
265
295
Adjusted Profit after Tax - Continuing Operations (pre excepts and amort)
205
223
Average diluted shares (m) (including impact of share buyback)
420.3
448.1
Adjusted diluted EPS (p) - continuing
48.8
49.9
Dividend/Share (p)
19.7
20.3
$/£ assumption (average rate)
1.26
1.26
€/£ assumption (average rate)
1.19
1.20
Group Cash Flow Statement (£m)
Adjusted Free cash flow (before exceptional cash flows)
191
192
Other cash flows in the year
Closing net debt
(983)
(875)

Disclaimer

Tate & Lyle PLC (“Tate & Lyle”) invites registered sell-side analysts that monitor Tate & Lyle’s stock to submit their forecasts to an external, web-based tool managed
by Vuma Financial Limited (“Vuma”), a company independent of Tate & Lyle.

The web-based tool generates an aggregation of publicly available forecasts collated exclusively by Vuma, but only on the basis of information submitted by those
analysts who choose to participate. The arithmetic average of the constituent analyst forecasts is known as “Consensus”. Vuma has no access to Tate & Lyle's
internal forecasts, budgets or any other information which is not publicly available.

Tate & Lyle has not commented on individual forecasts nor does it intend to do so in the future. Tate & Lyle assumes no obligation to update or revise such
information and nothing in this analysis should be taken as a recommendation to buy or sell shares in Tate & Lyle or to take any other action or place any reliance
on the analysis.

Consensus figures are provided for information only, and neither Tate & Lyle nor any of its subsidiary undertakings nor any director, officer or employee of
Tate & Lyle or any of its subsidiary undertakings accepts any responsibility for the accuracy or completeness of forecasts used in this analysis and therefore shall
have no liability whatsoever for the consequences of any reliance or actions taken or not taken based on any of the information in this analysis.